Ballicules.com

Prednisolone

ORAPRED

What it isActive glucocorticoid-receptor agonist; systemic treatment of inflammatory and immune disorders.

Why it mattersUnlike prednisone, it requires no hepatic activation and is available in child-friendly liquid formulations.

What it changesHyperglycemia, infection, mood effects and bone loss accumulate with exposure; prolonged use suppresses the adrenal axis and requires tapering.

FDA-approved for

FDA label

FDA dosingPopulationStartTargetMax
Corticosteroid-responsive disordersAdult5 mg QDindividualized to lowest effective dose60 mg/day

Renal Undefined

Hepatic Undefined

Instructions

Contraindications

Cautions

Adverse reactions

Pregnancy No adequate human studies; weigh benefit vs risk; observe infants of treated mothers for hypoadrenalism

Lactation Undefined

NO BOXED WARNINGS

Principal riskAdrenal suppression with prolonged use

Cost, est. cash$4–$300/month

Generic entry1983

Classes and tags

Clinical profile

Therapeutic safety burden3 / 4
Overdose danger2 / 4
Weight-gain liability3 / 4
Sedation liability0 / 4
QT / Torsades0 / 4
Direct muscarinic antagonism0 / 4
Embryofetal risk2 / 4

Legacy pregnancy categoryC

Defining liabilityHyperglycemia, infection, osteoporosis and potentially severe mood, sleep or psychotic effects.

Mechanism of action: Prednisolone ballicule

Prednisolone ballicule: receptor binding, kinetics and half-life diagram

Open Prednisolone in the interactive console ↗

Memory aids: mascots and interaction avatars

Prednisolone ORAPRED mascot mnemonic cartoon
“Solo prednisone”
Active glucocorticoid, the form prednisone is converted to
Prednisolone CYP3A4 substrate avatar
CYP3A4 substrate

Open Prednisolone in the interactive console ↗